Bioresorbable Medical Material Market Report 2026
Global Outlook – By Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)), By Application (Drug Delivery, Orthopedics, Other Applications), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users) - Market Size, Trends, Strategies, and Forecast to 2030
Bioresorbable Medical Material Market Overview
• Bioresorbable Medical Material market size has reached to $1.71 billion in 2025 • Expected to grow to $2.77 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Increasing Number Of Surgeries Propels The Bioresorbable Medical Material Market • Market Trend: Breakthrough In Bioresorbable 3D Printing Reshapes The Medical Material Landscape • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Bioresorbable Medical Material Market?
Bioresorbable medical materials refer to materials that are designed to be absorbed or broken down by the body over time. These materials are used in various medical applications, such as surgical implants and tissue engineering scaffolds, that offer several advantages over permanent implants and eliminate the need for surgical removal once the desired function is achieved. The main types of bioresorbable medical materials are polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL), and polylactic-co-glycolic acid (PLGA). Polylactic acid (PLA) is a biodegradable and bioresorbable polymer derived from renewable sources such as corn starch or sugarcane and is commonly used in bioresorbable medical materials, including sutures, screws, and bone fixation devices. These materials are used in several applications, such as drug delivery, orthopedics, and others, by end-users, including hospitals and clinics, ambulatory surgical centers, research institutes, and others.
What Is The Bioresorbable Medical Material Market Size and Share 2026?
The bioresorbable medical material market size has grown strongly in recent years. It will grow from $1.71 billion in 2025 to $1.88 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to growing use of biodegradable polymers in medical devices, increasing surgical implant procedures, rising demand for minimally invasive treatments, advancements in polymer chemistry, expansion of biomedical research activities.What Is The Bioresorbable Medical Material Market Growth Forecast?
The bioresorbable medical material market size is expected to see rapid growth in the next few years. It will grow to $2.77 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine solutions, rising demand for next-generation implant materials, expansion of personalized medical devices, growing investments in tissue engineering technologies, increasing focus on reducing secondary surgeries. Major trends in the forecast period include increasing adoption of bioresorbable polymer implants, rising use of temporary medical implants, growing demand for advanced tissue engineering scaffolds, expansion of drug-eluting bioresorbable devices, enhanced focus on controlled degradation materials.
Global Bioresorbable Medical Material Market Segmentation
1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA) 2) By Application: Drug Delivery, Orthopedics, Other Applications 3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users Subsegments: 1) By Polylactic Acid (PLA): Low Molecular Weight PLA, High Molecular Weight PLA, PLA Blends 2) By Polyglycolic Acid (PGA): Homopolymer PGA, Copolymer PGA 3) By Polysaccharides: Chitosan, Alginate, Hyaluronic Acid Derivatives 4) By Polycaprolactone (PCL): Standard PCL, PCL Copolymers 5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA, 75:25 PLGAWhat Is The Driver Of The Bioresorbable Medical Material Market?
The increasing number of surgeries is expected to propel the growth of the bioresorbable medical material market going forward. Surgical procedures refer to medical treatment that involves making an incision and using tools to stop or repair disease in a living body. Bioresorbable polymers are used in molded medical equipment, particularly those used in neurology, orthopedics, and cosmetic surgery. Bioresorbable materials can be used to make sutures, anchors, and screws. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, aesthetic procedures reached nearly 35 million in 2023, with the total number of surgical and non-surgical procedures rising by 3.4% to 34.9 million. Therefore, the increasing number of surgeries is driving the growth of the bioresorbable medical material industry.Key Players In The Global Bioresorbable Medical Material Market
Major companies operating in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Bioresorbable Medical Material Market Trends and Insights
Major companies operating in the bioresorbable medical material market are focusing on developing novel biomaterials for 3D printing applications to sustain their position in the industry. Novel biomaterials are advanced, bioresorbable materials engineered to safely degrade in the body while supporting the development of high-performance medical devices. For instance, in September 2023, Zeus Industrial Products, Inc., a US-based company specializing in advanced polymer solutions, launched next-generation tubing for bioresorbable vascular scaffolds named Absorv XSE. This product enhances the capabilities of vascular treatment devices by offering extensive customization across polymer types and sizes, enabling tailored mechanical and absorption properties. Absorv XSE ensures improved wall-thickness uniformity for consistent production and provides about 25% more usable scaffolds after laser cutting compared to earlier versions.What Are Latest Mergers And Acquisitions In The Bioresorbable Medical Material Market?
In April 2024, ProMed Pharma, a US-based contract manufacturer that specializes in the production of polymer-based drug-releasing dosage forms and combination device components., acquired SpineThera. for an undisclosed amount. This acquisition is strategically designed to strengthen ProMed Pharma's position in the market by enhancing its manufacturing capabilities, expanding its product offerings, and supporting innovative drug development initiatives. SpineThera. is a US-based clinical-stage pharmaceutical company that focuses on developing innovative injectable drugs, particularly utilizing its proprietary micro-suspension platform technology.
Regional Outlook
North America was the largest region in the bioresorbable medical material market in 2025. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Bioresorbable Medical Material Market?
The bioresorbable medical materials market consists of sales of chitosan, collagen, and calcium phosphates. Values in this market are ‘factory gat’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Bioresorbable Medical Material Market Report 2026?
The bioresorbable medical material market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable medical material industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Bioresorbable Medical Material Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.88 billion |
| Revenue Forecast In 2030 | $2.77 billion |
| Growth Rate | CAGR of 10.1% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain |
| Key Companies Profiled | Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |